FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090660616> ?p ?o ?g. }

• W2090660616 endingPage "333" @default.
• W2090660616 startingPage "319" @default.
• W2090660616 abstract "The different isoforms of the cytochrome P450 (CYP) system can metabolise a suite of classes of lipophilic, anthropogenic compounds. The bioaccumulative potential as well as the toxicity of xenobiotics may be significantly altered in the process. To compare the metabolic ability of different wildlife species, it is important to identify the different iso-enzymes of CYP, which are responsible for the metabolism of different classes of compounds. This can be achieved with in vitro incubation assays. In the present study, preparations of hepatic microsomes of a harbour seal (Phoca vitulina) and a grey seal (Halichoerus grypus) demonstrated that the chlorobornane (CHB) congeners CHB-32 and -62 were metabolised enzymatically to their hydroxylated derivatives. These derivatives were partially characterised by their NCI mass-spectra. Inhibition studies were carried out to identify the specific CYP isoform(s) responsible for the metabolism of CHB-32 and -62. Ketoconazole has been shown to inhibit CYP3A enzymes in human and rat studies. In this study, ketoconazole caused concentration-dependent inhibition of metabolism of CHB-32 and -62, reaching 80% at the 1.0 microM treatment level. Ellipticine (1.0 microM), which has been shown to inhibit CYP1A1/2, also inhibited CHB-32 and -62 metabolism in the microsomes of grey seal, but to a much lower degree of less than 10 and 24%, respectively. In the same experiment the metabolism of 4,4'-dichlorobiphenyl was already inhibited 70% by ellipticine treatment at the same concentration. This non-ortho substituted PCB congener can easily attain a planar molecular configuration, and therefore served as a model CYP1A substrate. Inhibition of chlorobornane metabolism was not observed after the addition of goat anti-rat CYP2B antibodies or Aldrin, which is a model CYP2B substrate in rat. Cautious interpretation is advised for results obtained with so-called selective competitive inhibitors. Regardless, these studies indicated for the first time the possible involvement a CYP3A isoform in the mediation of chlorobornane metabolism in seals. The immunochemical cross-reactivity of mouse, rabbit or sheep anti-rat antibodies in the hepatic microsomes of harbour seal confirmed the presence of CYP1A1/2, CYP1A1, CYP2B1/2, CYP3A and CYP4A isoenzymes. Enantioselective metabolism by the microsomes of harbour seal was observed for both CHB-32 and -62. Stereochemical preferences of biotransformation enzymes can have an influence on the environmental distribution of both enantiomers of optically active compounds." @default.
• W2090660616 created "2016-06-24" @default.
• W2090660616 creator A5028326798 @default.
• W2090660616 creator A5028962616 @default.
• W2090660616 creator A5043724346 @default.
• W2090660616 creator A5047098902 @default.
• W2090660616 creator A5048847773 @default.
• W2090660616 creator A5051571492 @default.
• W2090660616 creator A5066056921 @default.
• W2090660616 date "2001-01-01" @default.
• W2090660616 modified "2023-10-06" @default.
• W2090660616 title "Indications for the involvement of a CYP3A-like iso-enzyme in the metabolism of chlorobornane (Toxaphene®) congeners in seals from inhibition studies with liver microsomes" @default.
• W2090660616 cites W1497788006 @default.
• W2090660616 cites W1575870284 @default.
• W2090660616 cites W1963675326 @default.
• W2090660616 cites W1969967309 @default.
• W2090660616 cites W1978382373 @default.
• W2090660616 cites W2003237988 @default.
• W2090660616 cites W2003356062 @default.
• W2090660616 cites W2006156350 @default.
• W2090660616 cites W2011245669 @default.
• W2090660616 cites W2013726949 @default.
• W2090660616 cites W2021196370 @default.
• W2090660616 cites W2022951102 @default.
• W2090660616 cites W2033164183 @default.
• W2090660616 cites W2033274723 @default.
• W2090660616 cites W2037812043 @default.
• W2090660616 cites W2040575409 @default.
• W2090660616 cites W2050020962 @default.
• W2090660616 cites W2052193954 @default.
• W2090660616 cites W2054948990 @default.
• W2090660616 cites W2056295980 @default.
• W2090660616 cites W2063436364 @default.
• W2090660616 cites W2078425368 @default.
• W2090660616 cites W2091910905 @default.
• W2090660616 cites W2092191147 @default.
• W2090660616 cites W2096231029 @default.
• W2090660616 cites W2132927623 @default.
• W2090660616 cites W4293247451 @default.
• W2090660616 doi "https://doi.org/10.1016/s0166-445x(00)00116-8" @default.
• W2090660616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11090893" @default.
• W2090660616 hasPublicationYear "2001" @default.
• W2090660616 type Work @default.
• W2090660616 sameAs 2090660616 @default.
• W2090660616 citedByCount "30" @default.
• W2090660616 countsByYear W20906606162012 @default.
• W2090660616 countsByYear W20906606162014 @default.
• W2090660616 countsByYear W20906606162017 @default.
• W2090660616 countsByYear W20906606162020 @default.
• W2090660616 crossrefType "journal-article" @default.
• W2090660616 hasAuthorship W2090660616A5028326798 @default.
• W2090660616 hasAuthorship W2090660616A5028962616 @default.
• W2090660616 hasAuthorship W2090660616A5043724346 @default.
• W2090660616 hasAuthorship W2090660616A5047098902 @default.
• W2090660616 hasAuthorship W2090660616A5048847773 @default.
• W2090660616 hasAuthorship W2090660616A5051571492 @default.
• W2090660616 hasAuthorship W2090660616A5066056921 @default.
• W2090660616 hasConcept C107872376 @default.
• W2090660616 hasConcept C109650736 @default.
• W2090660616 hasConcept C115448650 @default.
• W2090660616 hasConcept C11824378 @default.
• W2090660616 hasConcept C161176658 @default.
• W2090660616 hasConcept C181199279 @default.
• W2090660616 hasConcept C185592680 @default.
• W2090660616 hasConcept C2775997484 @default.
• W2090660616 hasConcept C2777477808 @default.
• W2090660616 hasConcept C2779357283 @default.
• W2090660616 hasConcept C2779548794 @default.
• W2090660616 hasConcept C2780457584 @default.
• W2090660616 hasConcept C2781064554 @default.
• W2090660616 hasConcept C526171541 @default.
• W2090660616 hasConcept C55493867 @default.
• W2090660616 hasConcept C62231903 @default.
• W2090660616 hasConcept C6557445 @default.
• W2090660616 hasConcept C86803240 @default.
• W2090660616 hasConcept C87644729 @default.
• W2090660616 hasConcept C89311334 @default.
• W2090660616 hasConcept C89423630 @default.
• W2090660616 hasConcept C90856448 @default.
• W2090660616 hasConceptScore W2090660616C107872376 @default.
• W2090660616 hasConceptScore W2090660616C109650736 @default.
• W2090660616 hasConceptScore W2090660616C115448650 @default.
• W2090660616 hasConceptScore W2090660616C11824378 @default.
• W2090660616 hasConceptScore W2090660616C161176658 @default.
• W2090660616 hasConceptScore W2090660616C181199279 @default.
• W2090660616 hasConceptScore W2090660616C185592680 @default.
• W2090660616 hasConceptScore W2090660616C2775997484 @default.
• W2090660616 hasConceptScore W2090660616C2777477808 @default.
• W2090660616 hasConceptScore W2090660616C2779357283 @default.
• W2090660616 hasConceptScore W2090660616C2779548794 @default.
• W2090660616 hasConceptScore W2090660616C2780457584 @default.
• W2090660616 hasConceptScore W2090660616C2781064554 @default.
• W2090660616 hasConceptScore W2090660616C526171541 @default.
• W2090660616 hasConceptScore W2090660616C55493867 @default.
• W2090660616 hasConceptScore W2090660616C62231903 @default.
• W2090660616 hasConceptScore W2090660616C6557445 @default.
• W2090660616 hasConceptScore W2090660616C86803240 @default.
• W2090660616 hasConceptScore W2090660616C87644729 @default.

• next